Text Size
2697 studies found for:    Open Studies | chemotherapy

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
21 Not yet recruiting Combining Curcumin With FOLFOX Chemotherapy in Patients With Inoperable Colorectal Cancer
Conditions: Colonic Cancer;   Metastasis
Interventions: Drug: Oral complex C3 curcumin + chemotherapy;   Drug: Chemotherapy only
22 Recruiting 1st Line Chemotherapy Alone or With Bevacizumab in Treating Older Patients With Metastatic Colorectal Cancer
Condition: Colorectal Cancer
Interventions: Drug: Chemotherapy ( FOLFIRI regimen, FOLFOX regimen or LV5FU2 regimen);   Drug: Chemotherapy ( FOLFIRI regimen, FOLFOX regimen or LV5FU2 regimen) + bevacizumab
23 Not yet recruiting Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or Advanced Myelodysplastic Syndrome
Conditions: Adult Acute Megakaryoblastic Leukemia (M7);   Adult Acute Minimally Differentiated Myeloid Leukemia (M0);   Adult Acute Monoblastic Leukemia (M5a);   Adult Acute Monocytic Leukemia (M5b);   Adult Acute Myeloblastic Leukemia With Maturation (M2);   Adult Acute Myeloblastic Leukemia Without Maturation (M1);   Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities;   Adult Acute Myeloid Leukemia With Del(5q);   Adult Acute Myeloid Leukemia With Inv(16)(p13;q22);   Adult Acute Myeloid Leukemia With t(16;16)(p13;q22);   Adult Acute Myeloid Leukemia With t(8;21)(q22;q22);   Adult Acute Myelomonocytic Leukemia (M4);   Adult Erythroleukemia (M6a);   Adult Pure Erythroid Leukemia (M6b);   de Novo Myelodysplastic Syndromes;   Untreated Adult Acute Myeloid Leukemia
Intervention: Drug: chemotherapy
24 Recruiting Trial of Chemotherapy in Ovarian, Fallopian Tube and Peritoneal Carcinoma
Conditions: Primary Peritoneal Carcinoma;   Ovarian Carcinoma;   Fallopian Tube Carcinoma
Intervention: Drug: neoadjuvant chemotherapy
25 Recruiting Induction Chemotherapy (R-CHOP Vs. R-FC) Followed by Interferon Maintenance Versus Rituximab Maintenance in MCL
Condition: Lymphoma, Mantle-Cell
Interventions: Drug: Rituximab;   Drug: Cyclophosphamide;   Drug: Doxorubicin;   Drug: Vincristine;   Drug: Prednisone;   Drug: Fludarabine;   Drug: Interferon-alpha;   Drug: pegylated formula Interferon-alpha 2b;   Procedure: chemotherapy: R-CHOP;   Procedure: chemotherapy: R-FC;   Procedure: Interferon maintenance;   Procedure: Rituximab maintenance
26 Recruiting NPC Staged N2-3M0:Adjuvant Chemotherapy or Just Observation After Concurrent Chemoradiation
Condition: Nasopharyngeal Carcinoma
Intervention: Drug: Adjuvant chemotherapy with paclitaxel and nedaplatin
27 Recruiting Nimotuzumab in Combination With TPF(Cisplatin ,Fluorouracil and Docetaxel) for Head and Neck Squamous Cell Carcinoma
Condition: Head and Neck Squamous Cell Carcinoma
Interventions: Drug: Chemotherapy;   Drug: Nimotuzumab and Chemotherapy
28 Recruiting p53 Gene Therapy for Head and Neck Malignant Tumors in Advanced Stage
Condition: Neoplasms
Interventions: Drug: chemotherapy plus p53;   Drug: chemotherapy;   Radiation: radiotherapy
29 Recruiting Pancreas Cancer: Molecular Profiling as a Guide to Therapy Before and After Surgery ("Personalized Medicine")
Condition: Pancreatic Adenocarcinoma
Interventions: Drug: Targeted chemotherapy prior to surgery;   Drug: standard FOLFIRINOX chemotherapy prior to surgery;   Drug: Gemcitabine after surgery;   Other: No additional therapy after surgery;   Drug: Targeted chemotherapy after surgery;   Radiation: Chemoradiotherapy (cXRT)
30 Recruiting Efficacy of Capecitabine Metronomic Chemotherapy to Triple-negative Breast Cancer
Condition: Breast Cancer
Interventions: Drug: Capecitabine (Xeloda);   Drug: Standard adjuvant chemotherapy
31 Recruiting Neo-adjuvant Erbitux-based Chemotherapy for Locally Advanced Oral/Oropharyngeal Cancer
Conditions: Locally Advanced Malignant Neoplasm;   Oral Cancer;   Oropharyngeal Carcinoma
Intervention: Drug: Neo-adjuvant Erbitux-based chemotherapy
32 Unknown † A Study of Endostar Combined With Chemotherapy Followed by Endostar Maintenance Therapy to Treat Advanced Non-small Cell Lung Cancer (NSCLC)
Condition: Non-small Cell Lung Cancer (NSCLC)
Interventions: Drug: Endostar;   Drug: Gemcitabine-Cisplatin chemotherapy
33 Not yet recruiting Adjuvant Chemotherapy in Patients With High Risk Stage I Non-squamous Non-Small Cell Lung Cancer
Condition: Non-Small Cell Lung Cancer
Interventions: Drug: Adjuvant Chemotherapy;   Other: Radiographic surveillance;   Other: Pervenio™ Lung RS Assay
34 Recruiting Optimal Timing of Physical Activity in Cancer Treatment
Conditions: Metabolic Syndrome;   Vascular Disorders;   Cardiovascular Risk Factors;   Fatigue
Interventions: Other: A tailored physical activity program during chemotherapy;   Other: A tailored physical activity program after chemotherapy
35 Recruiting Nimotuzumab in Combination With Chemoradiation for Local Advanced Esophageal Squamous Cell Carcinoma
Condition: Local Advanced Esophageal Squamous Cell Carcinoma
Interventions: Drug: Placebo, Radiotherapy and Chemotherapy;   Drug: Nimotuzumab, Radiotherapy and Chemotherapy
36 Recruiting TPF Induction Chemotherapy for Locally Advanced and Resectable Oral Squamous Cell Carcinoma
Conditions: Stage III Oral Cavity Squamous Cell Carcinoma;   Stage IVA Oral Cavity Squamous Cell Carcinoma
Intervention: Drug: TPF induction chemotherapy
37 Recruiting Radiotherapy Followed by Adjuvant Chemotherapy in NK/T-cell Lymphoma
Condition: Extranodal NK/T-cell Lymphoma, Nasal Type
Intervention: Drug: Radiotherapy followed by chemotherapy
38 Recruiting Chemotherapy Followed By Surgery Vs Radiotherapy Plus Chemotherapy in Patients With Stage IB or II Cervical Cancer
Condition: Cervical Cancer
Interventions: Procedure: conventional surgery;   Procedure: neoadjuvant chemotherapy;   Radiation: brachytherapy;   Radiation: radiation therapy;   Drug: cisplatin
39 Recruiting Adjuvant Versus Neoadjuvant Plus Adjuvant Chemotherapy in Resectable Pancreatic Cancer
Condition: Pancreatic Cancer
Interventions: Drug: Neoadjuvant Chemotherapy with gemcitabine/oxaliplatin;   Drug: adjuvant chemotherapy with gemcitabine
40 Recruiting A Study of Endostar Combined With Chemotherapy for Treatment of Osteosarcoma
Condition: Osteosarcoma
Interventions: Drug: Chemotherapy;   Drug: Endostar
To Top

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
† Indicates status has not been verified in more than two years